Prostate-specific antigen testing across the spectrum of prostate cancer.
about
Current status of biomarkers for prostate cancerCirculating microRNAs: potential biomarkers for common malignanciesEvaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.The risks of information in health care: do we need a new decision aid?Mean Platelet Volume-A Predictive Factor for the Diagnosis of Nonsymptomatic Prostatitis: Results of Univariate and Multivariate Models.
P2860
Prostate-specific antigen testing across the spectrum of prostate cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prostate-specific antigen testing across the spectrum of prostate cancer.
@ast
Prostate-specific antigen testing across the spectrum of prostate cancer.
@en
Prostate-specific antigen testing across the spectrum of prostate cancer.
@nl
type
label
Prostate-specific antigen testing across the spectrum of prostate cancer.
@ast
Prostate-specific antigen testing across the spectrum of prostate cancer.
@en
Prostate-specific antigen testing across the spectrum of prostate cancer.
@nl
prefLabel
Prostate-specific antigen testing across the spectrum of prostate cancer.
@ast
Prostate-specific antigen testing across the spectrum of prostate cancer.
@en
Prostate-specific antigen testing across the spectrum of prostate cancer.
@nl
P2860
P356
P1476
Prostate-specific antigen testing across the spectrum of prostate cancer.
@en
P2093
Mark R Haythorn
Richard J Ablin
P2860
P304
P356
10.2217/BMM.11.53
P577
2011-08-01T00:00:00Z